Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pirfenidone in Coal Workers' Pneumoconiosis
NCT04461587Phase 2Completed
- Sponsor
- Pulmonary Research
- Start
- Aug 2020
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pirfenidone in coal workers' pneumoconiosis (CWP), sponsored by Pulmonary Research. Started Aug 2020; status: completed.
02
Drugs
pirfenidone
03
Conditions
coal workers' pneumoconiosis (CWP)
Beyond the preview
Go deeper on NCT04461587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04461587.